Pieris Pharmaceuticals, Inc.
(NASDAQ : PIRS)

( )
PIRS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.98%81.590.9%$637.74m
CELGCelgene Corporation
-0.88%135.961.1%$563.57m
AMGNAmgen Inc.
-1.16%184.121.1%$451.54m
BIIBBiogen Inc.
-0.63%342.421.2%$397.97m
REGNRegeneron Pharmaceuticals, Inc.
0.36%440.942.7%$313.46m
ALNYAlnylam Pharmaceuticals, Inc
-1.63%115.6310.7%$252.14m
VRTXVertex Pharmaceuticals Incorporated
-0.10%154.601.9%$218.27m
INCYIncyte Corporation
-0.76%114.272.5%$205.56m
ALXNAlexion Pharmaceuticals, Inc.
0.16%140.461.9%$180.37m
EXELExelixis, Inc.
-0.25%27.466.5%$136.95m
ILMNIllumina, Inc.
-0.21%205.183.5%$132.63m
BLUEBluebird Bio, Inc.
0.25%139.4517.3%$114.79m
BMRNBioMarin Pharmaceutical Inc.
-0.55%88.134.4%$113.12m
SRPTSarepta Therapeutics, Inc.
-1.36%50.7216.9%$105.98m
CLVSClovis Oncology, Inc.
-2.48%76.7716.5%$102.15m

Company Profile

Pieris Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that engages in the discovery and development of Anticalin class of biotherapeutics. It offers technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with an unmet medical need. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.